|
|
|
| home > white papers > Technology Solutions - Driving efficiencies, quality and operational excellence - Worldwide Clinical Trials Ltd |
|
|
 WHITE PAPERS |
|
|
Worldwide Clinical Trials Ltd
|
|
Technology Solutions - Driving efficiencies, quality and operational excellence
|
|
Clinical trials involve the entry, analysis and reporting of millions of
pieces of data; year-on-year, the amount of data required to manage
efficacy and safety increases exponentially. Recently, solutions
available to support this activity have grown in numbers and complexity.
The rise of Tablets and Smart Phones combined with the growth of Cloud
or SAS solutions has resulted in the technology landscape required to
support complex, global studies becoming more confusing.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Immunic, Inc. Added to NASDAQ Biotechnology Index
NEW YORK, Dec. 14, 2020 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq: NBI), effective prior to market open on Monday, December 21, 2020.
More info >> |
|
 |
White Papers |
 |
|
Overcoming research challenges with Adaptive Trials
PCI Pharma Services
There has been cause for concern within the pharmaceutical industry over
the last five years, regarding increasing research and development
costs, combined with a fall in the number of new drugs brought to
market. In an attempt to overcome this issue there has been a
significant rise in the use of adaptive clinical trial designs, whilst
saving time and money as well as facilitating more effective decision
making. One of the biggest challenges that pharmaceutical companies have
experienced has been delivering compliant clinical trials supplies
across diverse patient populations in the relatively short timeframes
that adaptive trial designs require, remaining focused on ensuring that
patient compliance and product quality is in no way compromised. This
demand has led to the launch of fast response services that support
Research and Development in responding to changing dosing regimens
mid-trial.
More info >> |
|
 |
Industry Events |
 |
Bio Integrates 2021
20 May 2021, VIRTUAL CONFERENCE
Following the continued success of last year’s inaugural digital event,
Life Science Integrates is delighted to announce the 3rd Bio Integrates
conference. Addressing the needs of innovative companies developing the
therapies of tomorrow, this one-day conference provides a unique forum
to discuss the major challenges impacting the sector.
More info >> |
|
|
|
